Spirit-Quieting Traditional Chinese Medicine may Improve Survival in Prostate Cancer Patients with Depression
- PMID: 30744039
- PMCID: PMC6406565
- DOI: 10.3390/jcm8020218
Spirit-Quieting Traditional Chinese Medicine may Improve Survival in Prostate Cancer Patients with Depression
Abstract
Depression is associated with higher mortality in prostate cancer. However, whether traditional Chinese medicine (TCM) for depression improves outcomes in patients with prostate cancer is unclear. This retrospective cohort study evaluated the association between TCM for depression and mortality in patients with prostate cancer. During the period 1998⁻2012, a total of 248 prostate cancer patients in Taiwan with depression were enrolled and divided into three groups: TCM for depression (n = 81, 32.7%), TCM for other purposes (n = 53, 21.3%), and no TCM (n = 114, 46.0%). During a median follow-up of 6.2 years, 12 (14.8%), 13 (24.5%), and 36 (31.6%) deaths occurred in the TCM for depression, TCM for other purposes, and no TCM groups, respectively. After adjusting age at diagnosis, urbanization, insured amount, comorbidity disease, and prostate cancer type, TCM for depression was associated with a significantly lower risk of overall mortality based on a multivariate-adjusted Cox proportional-hazards model (hazard ratio 0.42, 95% confidence interval: 0.21⁻0.85, p = 0.02) and Kaplan⁻Meier survival curve (log-rank test, p = 0.0055) compared to no TCM. In conclusion, TCM for depression may have a positive association with the survival of prostate cancer patients with depression.
Keywords: depression; prostate cancer; traditional Chinese medicine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer.Medicine (Baltimore). 2016 Aug;95(31):e4475. doi: 10.1097/MD.0000000000004475. Medicine (Baltimore). 2016. PMID: 27495088 Free PMC article.
-
Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: a population-based study.Cancer. 2014 May 1;120(9):1338-44. doi: 10.1002/cncr.28579. Epub 2014 Feb 3. Cancer. 2014. PMID: 24496917
-
Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.Phytomedicine. 2019 Sep;62:152930. doi: 10.1016/j.phymed.2019.152930. Epub 2019 May 11. Phytomedicine. 2019. PMID: 31128485 Clinical Trial.
-
Prescription of Chinese Herbal Medicine in Pattern-Based Traditional Chinese Medicine Treatment for Depression: A Systematic Review.Evid Based Complement Alternat Med. 2015;2015:160189. doi: 10.1155/2015/160189. Epub 2015 Jun 9. Evid Based Complement Alternat Med. 2015. PMID: 26180532 Free PMC article. Review.
-
Depression with Comorbid Diabetes: What Evidence Exists for Treatments Using Traditional Chinese Medicine and Natural Products?Front Pharmacol. 2021 Jan 25;11:596362. doi: 10.3389/fphar.2020.596362. eCollection 2020. Front Pharmacol. 2021. PMID: 33568996 Free PMC article. Review.
Cited by
-
Significant Tumor Reduction With Traditional Chinese Medicine in a Patient With Advanced Prostate Cancer: A Case Report.Am J Mens Health. 2022 Sep-Oct;16(5):15579883221130854. doi: 10.1177/15579883221130854. Am J Mens Health. 2022. PMID: 36314104 Free PMC article.
-
Actuarial Analysis of Survival among Breast Cancer Patients in Lithuania.Healthcare (Basel). 2021 Apr 1;9(4):383. doi: 10.3390/healthcare9040383. Healthcare (Basel). 2021. PMID: 33915700 Free PMC article.
-
Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice.Chin Herb Med. 2023 Sep 4;15(4):485-495. doi: 10.1016/j.chmed.2023.05.003. eCollection 2023 Oct. Chin Herb Med. 2023. PMID: 38094009 Free PMC article. Review.
-
Cohort Studies on Chronic Non-communicable Diseases Treated With Traditional Chinese Medicine: A Bibliometric Analysis.Front Pharmacol. 2021 Mar 19;12:639860. doi: 10.3389/fphar.2021.639860. eCollection 2021. Front Pharmacol. 2021. PMID: 33815122 Free PMC article. Review.
-
Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating sphingolipid and glycerinphospholipid metabolism.Front Pharmacol. 2022 Dec 5;13:1011450. doi: 10.3389/fphar.2022.1011450. eCollection 2022. Front Pharmacol. 2022. PMID: 36545317 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources